Pancreatic Disease Center

The Pancreatic Disease Center at the University of Cincinnati is a multidisciplinary unit that provides complete evaluation and therapy of pancreatic disorders, as well as consultations to referring physicians. Eligible patients may participate in clinical research protocols in the treatment of pain due to chronic pancreatitis as well as neoadjuvent chemoradiation therapy for pancreatic cancer. The autologous islet cell transplant program is one of only two major centers in the U.S., and has been very successful in treating pancreatitis, while allowing patients to live normally, with little to no insulin dependence.

Among the most active such programs in the world, the Pancreatic Disease Center, which opened in 2000 with approximately 20 patients per week, now sees approximately 60 patients per week. Recent patients have come from as far as New Mexico, Vermont, Montana, Idaho, Florida, Texas, and Connecticut.

A wide range of specific pancreatic problems are diagnosed, evaluated and treated, including complicated or recurrent acute pancreatitis, chronic pancreatitis, cystic lesions of the pancreas, and pancreatic cancers. The Center offers some of the country’s foremost pancreatic disease specialists, quick evaluation of patients and rapid turnaround of diagnostic tests, providing answers before patients leave the premises, on-site treatments ranging from the most simple and basic, to cutting-edge and complex, participation in a vast array of breakthrough clinical research protocols, first-class diagnostic, research and patient care facilities.

An annual Pancreatic Disease Symposium is held for surgeons, gastroenterologists, and other interested participants. For information and online registration, visit http://www.ucpancreas.org.